Chimp Check: NIH Seeks Input on Primate Research Paperwork
Published Date: 2/19/2026
Notice
Summary
The NIH wants to keep using a form that helps them check if chimpanzee research follows their rules. They’re asking the public to share thoughts by April 20, 2026, to make sure the form is useful and not too much work. This won’t cost extra money but helps keep research safe and fair for chimps and scientists alike.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
Funding Limited to Noninvasive Research
The NIH will not fund any research involving chimpanzees proposed in new or other competing projects unless the research is consistent with the definition of "noninvasive research" in the "Standards of Care for Chimpanzees Held in the Federally Supported Chimpanzee Sanctuary System" (42 CFR part 9). Researchers proposing chimpanzee studies must use the Chimpanzee Research Use Form and meet that noninvasive standard before NIH will consider funding or allow the research to begin.
Mandatory Chimpanzee Form Extended
The NIH is seeking to extend the Chimpanzee Research Use Form (OMB control 0925-0705) and asks for public comments by April 20, 2026. Completing the form is mandatory to receive NIH support for noninvasive chimpanzee research, OMB approval is requested for three years, and the agency estimates a total annual burden of 15 hours for 30 respondents (about 0.5 hours per response). There are no costs to respondents other than their time.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-03213 — Determination That TOLECTIN DS (Tolmetin Sodium) Capsule, Equivalent to 400 Milligrams Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that TOLECTIN DS (tolmetin sodium) 400 mg capsules weren’t taken off the market because of safety or effectiveness problems. This means generic drug makers can now apply to sell their own versions, as long as they meet all the rules. Patients and pharmacies could see more affordable options soon, with no safety worries holding things back!
Next: 2026-03215 — Establishment of Department of War Federal Advisory Committee-Science, Technical, and Innovation BoardF
The Department of War is creating a new Science, Technology, and Innovation Board (STIB) to combine and replace two older advisory groups. This fresh board will help guide the department on cool tech and innovation stuff, starting early 2026. If you’re interested, you can send in your ideas anytime, and this change aims to streamline advice without extra costs.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in